Nominations Now Open for 6th Annual Harrington Prize for Innovation in Medicine

Collaboration between ASCI and Harrington Discovery Institute; Prize includes $20,000 honorarium

CLEVELAND, May 1, 2018 /PRNewswire/ -- National and international nominations are being sought for the 2019 Harrington Prize for Innovation in Medicine, which honors a physician-scientist who has moved science forward with achievements notable for innovation, creativity and the potential for clinical application.

The deadline for nominations is August 28, 2018.

Nomination guidelines can be found at: HarringtonDiscovery.org/ThePrize.

The Harrington Prize, which carries a $20,000 honorarium, is a collaboration between The American Society for Clinical Investigation (ASCI), one of the nation’s oldest and most respected medical honor societies, and the Harrington Discovery Institute at University Hospitals in Cleveland, Ohio--part of The Harrington Project for Discovery & Development. The Harrington Discovery Institute is a nonprofit institute dedicated to supporting physician-scientists, and all scientists in areas of unmet therapeutic need, in their work to transform discoveries into medicines for the benefit of society.

Both organizations recognize the obstacles associated with turning discoveries into medicines, and they are eager to highlight those who have navigated the path successfully or whose work has led to novel treatments.

A committee composed of members of the ASCI Council and the Harrington Discovery Institute Scientific Advisory Board will review the nominations and select the awardee. In addition to the honorarium, the 2019 recipient will deliver the Harrington Prize Lecture at the 2019 Joint Meeting of the Association of American Physicians (AAP), the ASCI, and the American Physician Scientists Association (APSA) April 5-7, 2019; will participate at the 2019 Harrington Discovery Institute annual symposium May 22 -23, 2019; and will publish a personal essay in the Journal of Clinical Investigation.

Previous award winners are Helen H. Hobbs, MD (2018); Daniel J. Drucker, MD, Joel F. Habener, MD, and Jens J. Holst, MD, DMSc (2017 co-recipients); Jeffrey M. Friedman, MD, PhD (2016); Douglas R. Lowy, MD (2015); and Harry C. Dietz, MD (2014).

For questions or more information about the nomination requirements, visit HarringtonDiscovery.org/ThePrize or contact Bronwyn Monroe, Harrington Discovery Institute Program Director, at Bronwyn.Monroe@HarringtonDiscovery.org.

Harrington Discovery Institute
The Harrington Discovery Institute at University Hospitals in Cleveland, OH--part of The Harrington Project for Discovery & Development--aims to advance medicine and society by enabling our nation’s most inventive scientists to turn their discoveries into medicines that improve human health. The institute was created in 2012 with a $50 million founding gift from the Harrington family and instantiates the commitment they share with University Hospitals to a Vision for a ‘Better World.’

The Harrington Project for Discovery & Development
The Harrington Project for Discovery & Development (The Harrington Project), founded in late February 2012 by the Harrington Family and University Hospitals of Cleveland, is a $300 million national initiative built to bridge the translational ‘valley of death.’ It includes the Harrington Discovery Institute and BioMotiv, a for-profit, mission-aligned drug development company that accelerates early discovery into pharma pipelines.

For more information about The Harrington Project and the Harrington Discovery Institute, visit: HarringtonDiscovery.org.

University Hospitals
UH’s vision is “Advancing the science of health and the art of compassion,” and its mission: “To Heal. To Teach. To Discover.” Follow UH on Facebook @UniversityHospitals and Twitter @UHhospitals. For more information, go to UHhospitals.org.

CONTACT: George Stamatis, University Hospitals, george.stamatis@uhhospitals.org, 216-844-3667, John Hawley, ASCI, staff@the-asci.org, 734-222-6050, ext. 402